A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer

NCT01495676 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Infiltrating Bladder Urothelial Carcinoma

Interventions

OTHER: Radiation + cisplatin
OTHER: Radiation + cisplatin + gemcitabine

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle